Dan Iosifescu - Publications

Affiliations: 
1994-1996 Clinical Neuroscience Division, Laboratory of Neuroscience, Department of Psychiatry Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States 

186 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Reinen JM, Whitton AE, Pizzagalli DA, Slifstein M, Abi-Dargham A, McGrath PJ, Iosifescu DV, Schneier FR. Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 53: 89-100. PMID 34517334 DOI: 10.1016/j.euroneuro.2021.08.002  1
2021 Köhler-Forsberg O, Sloth KH, Sylvia LG, Thase M, Calabrese JR, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy SL, Shelton RC, Iosifescu DV, Ostacher MJ, et al. Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response. Psychiatry Research. 305: 114194. PMID 34500184 DOI: 10.1016/j.psychres.2021.114194  1
2021 Pizzagalli DA, Smoski M, Ang YS, Whitton AE, Sanacora G, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu DV, Murrough JW, Yang H, Weiner RD, Calabrese JR, Goodman W, Potter WZ, et al. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34389811 DOI: 10.1038/s41386-021-01145-9  1
2021 Iovieno N, Papakostas GI, Feeney A, Fava M, Mathew SJ, Iosifescu DI, Murrough JW, Macaluso M, Hock RS, Jha MK. Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset. The Journal of Clinical Psychiatry. 82. PMID 34133089 DOI: 10.4088/JCP.20r13682  1
2021 Feeney A, Hock RS, Freeman MP, Flynn M, Hoeppner B, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Fava M, Papakostas GI. The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 49: 122-132. PMID 34090255 DOI: 10.1016/j.euroneuro.2021.04.024  1
2021 McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American Journal of Psychiatry. appiajp202020081251. PMID 33726522 DOI: 10.1176/appi.ajp.2020.20081251  1
2021 Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, Iqbal T, Chadha N, Pizzagalli DA, Whitton A, Bevilacqua L, Jha MK, Ursu S, Swann AC, Collins KA, ... ... Iosifescu DV, et al. Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial. The American Journal of Psychiatry. appiajp202020050653. PMID 33653118 DOI: 10.1176/appi.ajp.2020.20050653  1
2021 Rette DN, Arnold MS, McDonald EM, Hoptman MJ, Collins KA, Iosifescu DV. Influences on childhood depressive symptoms: The effects of trauma and distress tolerance across age and sex groups. Journal of Affective Disorders. 283: 373-376. PMID 33578351 DOI: 10.1016/j.jad.2021.01.064  1
2021 Czamara D, Tissink E, Tuhkanen J, Martins J, Awaloff Y, Drake AJ, Khulan B, Palotie A, Winter SM, Nemeroff CB, Craighead WE, Dunlop BW, Mayberg HS, Kinkead B, Mathew SJ, ... Iosifescu DV, et al. Combined effects of genotype and childhood adversity shape variability of DNA methylation across age. Translational Psychiatry. 11: 88. PMID 33526782 DOI: 10.1038/s41398-020-01147-z  1
2021 Goldberg JF, Nierenberg AA, Iosifescu DV. Wrestling With Antidepressant Use in Bipolar Disorder: The Ongoing Debate. The Journal of Clinical Psychiatry. 82. PMID 33471445 DOI: 10.4088/JCP.19ac13181  1
2020 Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry. 11: 595584. PMID 33424664 DOI: 10.3389/fpsyt.2020.595584  1
2020 Tural U, Iosifescu DV. A systematic review and network meta-analysis of carbon dioxide provocation in psychiatric disorders. Journal of Psychiatric Research. PMID 33250190 DOI: 10.1016/j.jpsychires.2020.11.032  1
2020 Eng GK, Collins KA, Brown C, Ludlow M, Tobe RH, Iosifescu DV, Stern ER. Dimensions of interoception in obsessive-compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders. 27. PMID 33194538 DOI: 10.1016/J.Jocrd.2020.100584  1
2020 de la Garrigue N, Glasser J, Sehatpour P, Iosifescu DV, Dias E, Carlson M, Shope C, Sobeih T, Choo TH, Wall MM, Kegeles LS, Gangwisch J, Mayer M, Brazis S, De Baun HM, et al. Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia . Journal of Psychiatry and Brain Science. 5. PMID 32856005  0.01
2020 Köhler-Forsberg O, Sylvia LG, Fung V, Overhage L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy SL, Shelton RC, ... ... Iosifescu DV, et al. Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials. Depression and Anxiety. PMID 32598093 DOI: 10.1002/da.23069  1
2020 Iosifescu DV. Are Electroencephalogram-Derived Predictors of Antidepressant Efficacy Closer to Clinical Usefulness? Jama Network Open. 3: e207133. PMID 32568395 DOI: 10.1001/jamanetworkopen.2020.7133  0.01
2020 Pizzagalli DA, Smoski M, Ang YS, Whitton AE, Sanacora G, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu DV, Murrough JW, Yang H, Weiner RD, Calabrese JR, Goodman W, Potter WZ, et al. Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32544925 DOI: 10.1038/S41386-020-0738-4  1
2020 Papakostas GI, Salloum NC, Hock RS, Jha MK, Murrough JW, Mathew SJ, Iosifescu DV, Fava M. Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis. The Journal of Clinical Psychiatry. 81. PMID 32459407 DOI: 10.4088/Jcp.19R12889  1
2020 Köhler-Forsberg O, Sylvia LG, Ruberto VL, Kuperberg M, Shannon AP, Fung V, Overhage L, Calabrese JR, Thase M, Bowden CL, Shelton RC, McInnis M, Deckersbach T, Tohen M, Kocsis JH, ... ... Iosifescu DV, et al. Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response. Journal of Affective Disorders. 273: 131-137. PMID 32421593 DOI: 10.1016/j.jad.2020.03.157  1
2020 Freeman MP, Hock RS, Papakostas GI, Judge H, Cusin C, Mathew SJ, Sanacora G, Iosifescu DV, DeBattista C, Trivedi MH, Fava M. Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder. Journal of Clinical Psychopharmacology. 40: 287-292. PMID 32332464 DOI: 10.1097/Jcp.0000000000001209  1
2020 Krystal AD, Pizzagalli DA, Smoski M, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu D, Murrough JW, Yang H, Weiner RD, Calabrese JR, Sanacora G, Hermes G, Keefe RSE, Song A, et al. A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. Nature Medicine. PMID 32231295 DOI: 10.1038/S41591-020-0806-7  1
2020 Tural U, Iosifescu DV. Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta-analysis. Journal of Neuroscience Research. PMID 32048334 DOI: 10.1002/jnr.24589  1
2020 Güleş E, Iosifescu DV, Tural Ü. Plasma Neuronal and Glial Markers and Anterior Cingulate Metabolite Levels in Major Depressive Disorder: A Pilot Study. Neuropsychobiology. 1-8. PMID 32045918 DOI: 10.1159/000505782  0.01
2020 Whitton AE, Reinen JM, Slifstein M, Ang YS, McGrath PJ, Iosifescu DV, Abi-Dargham A, Pizzagalli DA, Schneier FR. Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression. Brain : a Journal of Neurology. 143: 701-710. PMID 32040562 DOI: 10.1093/Brain/Awaa002  1
2020 Stern ER, Brown C, Ludlow M, Shahab R, Collins K, Lieval A, Tobe RH, Iosifescu DV, Burdick KE, Fleysher L. The buildup of an urge in obsessive-compulsive disorder: Behavioral and neuroimaging correlates. Human Brain Mapping. PMID 31916668 DOI: 10.1002/Hbm.24898  1
2020 Whitton A, Reinen J, Slifstein M, Ang Y, McGrath P, Iosifescu D, Abi-Dargham A, Pizzagalli D, Schneier F. Computational Approaches to Improving Treatment Precision for Anhedonia Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.153  1
2019 Hoch MM, Doucet GE, Moser DA, Hee Lee W, Collins KA, Huryk KM, DeWilde KE, Fleysher L, Iosifescu DV, Murrough JW, Charney DS, Frangou S, Iacoviello BM. Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for Depression. Chronic Stress (Thousand Oaks, Calif.). 3: 2470547019877880. PMID 32440602 DOI: 10.1177/2470547019877880  1
2019 Askalsky P, Iosifescu DV. Transcranial Photobiomodulation For The Management Of Depression: Current Perspectives. Neuropsychiatric Disease and Treatment. 15: 3255-3272. PMID 31819453 DOI: 10.2147/NDT.S188906  0.01
2019 Cassano P, Caldieraro MA, Norton R, Mischoulon D, Trinh NH, Nyer M, Dording C, Hamblin MR, Campbell B, Iosifescu DV. Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation. Photobiomodulation, Photomedicine, and Laser Surgery. 37: 651-656. PMID 31647774 DOI: 10.1089/photob.2019.4678  1
2019 Rette D, McDonald E, Iosifescu DV, Collins KA. Neural Predictors of the Antidepressant Placebo Response. Pharmaceuticals (Basel, Switzerland). 12. PMID 31635043 DOI: 10.3390/ph12040158  0.01
2019 Salloum NC, Fava M, Hock RS, Freeman MP, Flynn M, Hoeppner B, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression. Journal of Affective Disorders. 260: 131-139. PMID 31494365 DOI: 10.1016/J.Jad.2019.09.017  1
2019 Woods AG, Wormwood KL, Iosifescu DV, Murrough J, Darie CC. Protein Biomarkers in Major Depressive Disorder: An Update. Advances in Experimental Medicine and Biology. 1140: 585-600. PMID 31347073 DOI: 10.1007/978-3-030-15950-4_35  1
2019 Köhler-Forsberg O, Sylvia LG, Bowden CL, Calabrese JR, Thase ME, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, et al. Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials. Acta Neuropsychiatrica. 1-5. PMID 31169098 DOI: 10.1017/neu.2019.19  1
2019 Costi S, Soleimani L, Glasgow A, Brallier J, Spivack J, Schwartz J, Levitch CF, Richards S, Hoch M, Wade E, Welch A, Collins KA, Feder A, Iosifescu DV, Charney DS, et al. Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30858518 DOI: 10.1038/S41386-019-0365-0  1
2019 Jovanovic T, Duncan EJ, Kaye J, Garza K, Norrholm SD, Inslicht SS, Neylan TC, Mathew SJ, Iosifescu D, Rothbaum BO, Mayberg HS, Dunlop BW. Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients. Psychophysiology. e13356. PMID 30807663 DOI: 10.1111/Psyp.13356  1
2019 Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M. Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression. Journal of Psychiatric Research. 110: 166-171. PMID 30641350 DOI: 10.1016/J.Jpsychires.2019.01.010  1
2019 Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30617276 DOI: 10.1038/S41380-018-0311-2  1
2019 Thomas G, Dording C, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV, Cassano P. S198. Effects of Transcranial Photobiomodulation With Near-Infrared Light on Sexual Dysfunction Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.949  1
2019 Norton R, Caldieraro M, Mischoulon D, Trinh N, Nyer M, Dording C, Hamblin MR, Campbell B, Iosifescu DV, Cassano P. F85. Reported Side-Effects, Weight and Blood Pressure After Repeated Sessions of Transcranial Photobiomodulation Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.622  1
2018 Iacoviello BM, Murrough JW, Hoch MM, Huryk KM, Collins KA, Cutter GR, Iosifescu DV, Charney DS. A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression. Npj Digital Medicine. 1. PMID 30854473 DOI: 10.1038/s41746-018-0025-5  1
2018 Trigo TR, de Freitas CCS, Wang YP, Ribeiro FG, de Lucia MCS, Siqueira JO, Iosifescu DV, Hallak JEC, Fraguas R. The Influence of Depression on the Psychometric Properties of the Maslach Burnout Inventory-Human Services Survey: A Cross-Sectional Study With Nursing Assistants. Frontiers in Psychiatry. 9: 695. PMID 30618870 DOI: 10.3389/fpsyt.2018.00695  1
2018 Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depression and Anxiety. PMID 30597688 DOI: 10.1002/Da.22875  1
2018 Krystal AD, Pizzagalli DA, Mathew SJ, Sanacora G, Keefe R, Song A, Calabrese J, Goddard A, Goodman W, Lisanby SH, Smoski M, Weiner R, Iosifescu D, Nurnberger J, Szabo S, et al. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nature Reviews. Drug Discovery. 18: 82-84. PMID 30591715 DOI: 10.1038/Nrd.2018.222  1
2018 Tural U, Iosifescu DV. The Prevalence of Mitral Valve Prolapse in Panic Disorder: A Meta-Analysis. Psychosomatics. PMID 30448200 DOI: 10.1016/j.psym.2018.10.002  1
2018 Pape JC, Carrillo-Roa T, Rothbaum BO, Nemeroff CB, Czamara D, Zannas AS, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Dunlop BW, Binder EB. DNA methylation levels are associated with CRF receptor antagonist treatment outcome in women with post-traumatic stress disorder. Clinical Epigenetics. 10: 136. PMID 30390684 DOI: 10.1186/s13148-018-0569-x  1
2018 Tan A, Costi S, Morris LS, Van Dam NT, Kautz M, Whitton AE, Friedman AK, Collins KA, Ahle G, Chadha N, Do B, Pizzagalli DA, Iosifescu DV, Nestler EJ, Han MH, et al. Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder. Molecular Psychiatry. PMID 30385872 DOI: 10.1038/S41380-018-0283-2  1
2018 Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, ... ... Iosifescu DV, et al. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomedicine and Laser Surgery. PMID 30346890 DOI: 10.1089/Pho.2018.4490  1
2018 Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30283029 DOI: 10.1038/S41380-018-0256-5  1
2018 Cassano P, Dording C, Thomas G, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction. Lasers in Surgery and Medicine. PMID 30221776 DOI: 10.1002/Lsm.23011  1
2018 Gould F, Dunlop BW, Rosenthal JB, Iosifescu DV, Mathew SJ, Neylan TC, Rothbaum BO, Nemeroff CB, Harvey PD. Temporal Stability of Cognitive Functioning and Functional Capacity in Women with Posttraumatic Stress Disorder. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30124744 DOI: 10.1093/Arclin/Acy064  1
2018 Schneier FR, Slifstein M, Whitton AE, Pizzagalli DA, Reinen J, McGrath PJ, Iosifescu DV, Abi-Dargham A. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study. Biological Psychiatry. PMID 30041971 DOI: 10.1016/J.Biopsych.2018.05.014  1
2018 Richards C, Iosifescu DV, Mago R, Sarkis E, Geibel B, Dauphin M, McIntyre RS, Weisler R, Brawman-Mintzer O, Gu J, Madhoo M. A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. Journal of Clinical Psychopharmacology. PMID 29912786 DOI: 10.1097/Jcp.0000000000000897  1
2018 Hodgins GE, Blommel JG, Dunlop BW, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Harvey PD. Placebo Effects Across Self-Report, Clinician Rating, and Objective Performance Tasks Among Women With Post-Traumatic Stress Disorder: Investigation of Placebo Response in a Pharmacological Treatment Study of Post-Traumatic Stress Disorder. Journal of Clinical Psychopharmacology. PMID 29505471 DOI: 10.1097/JCP.0000000000000858  1
2018 Murrough JW, Huryk KM, Mao X, Iacoviello B, Collins K, Nierenberg AA, Kang G, Shungu DC, Iosifescu DV. A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo. Journal of Affective Disorders. 230: 56-64. PMID 29407539 DOI: 10.1016/J.Jad.2017.12.067  1
2018 Pape J, Carrillo-Roa T, Wiechmann T, Roeh S, Rothbaum B, Nemeroff C, Czamara D, Zannas A, Iosifescu D, Mathew S, Neylan T, Mayberg H, Dunlop B, Binder E. F179. Epigenetic Biomarkers in Women With Posttraumatic Stress Disorder After CRF1 Receptor Antagonist Treatment Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.793  1
2017 Köhler-Forsberg O, Sylvia L, Deckersbach T, Ostacher MJ, McInnis M, Iosifescu D, Bowden C, McElroy S, Calabrese J, Thase M, Shelton RC, Tohen M, Kocsis J, Friedman E, Ketter T, et al. Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder. Acta Neuropsychiatrica. 1-9. PMID 29212563 DOI: 10.1017/neu.2017.34  1
2017 Sayed S, Van Dam NT, Horn SR, Kautz MM, Parides M, Costi S, Collins KA, Iacoviello B, Iosifescu DV, Mathé AA, Southwick SM, Feder A, Charney DS, Murrough JW. A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder. The International Journal of Neuropsychopharmacology. PMID 29186416 DOI: 10.1093/Ijnp/Pyx109  1
2017 Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, et al. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimulation. PMID 29030111 DOI: 10.1016/J.Brs.2017.09.010  1
2017 Richards C, Iosifescu DV, Mago R, Sarkis E, Reynolds J, Geibel B, Dauphin M. A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy. Journal of Psychopharmacology (Oxford, England). 269881117722998. PMID 28857719 DOI: 10.1177/0269881117722998  1
2017 Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC, Pape JC, Carrillo-Roa T, Green C, Kinkead B, Grigoriadis D, Rothbaum BO, Nemeroff CB, Mayberg HS. Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder. Biological Psychiatry. PMID 28793974 DOI: 10.1016/j.biopsych.2017.06.024  1
2017 Murrough JW, Wade E, Sayed S, Ahle G, Kiraly DD, Welch A, Collins KA, Soleimani L, Iosifescu DV, Charney DS. Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial. Journal of Affective Disorders. 218: 277-283. PMID 28478356 DOI: 10.1016/J.Jad.2017.04.072  1
2017 Kellner CH, Iosifescu DV. Ketamine and ECT: better alone than together? The Lancet. Psychiatry. 4: 348-349. PMID 28359863 DOI: 10.1016/S2215-0366(17)30099-8  0.01
2017 Kiraly DD, Horn SR, Van Dam NT, Costi S, Schwartz J, Kim-Schulze S, Patel M, Hodes GE, Russo SJ, Merad M, Iosifescu DV, Charney DS, Murrough JW. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Translational Psychiatry. 7: e1065. PMID 28323284 DOI: 10.1038/Tp.2017.31  1
2017 Santos DM, Lage LV, Jabur EK, Kaziyama HHS, Iosifescu DV, De Lucia MCS, Fráguas R. The influence of depression on personality traits in patients with fibromyalgia: a case-control study. Clinical and Experimental Rheumatology. 35: 13-19. PMID 27782872  1
2016 Wade EC, Iosifescu DV. Using Electroencephalography for Treatment Guidance in Major Depressive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 1: 411-422. PMID 29560870 DOI: 10.1016/j.bpsc.2016.06.002  0.01
2016 Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY, Iosifescu DV, Charney DS, Murrough JW. Ketamine Treatment and Global Brain Connectivity in Major Depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27604566 DOI: 10.1038/Npp.2016.186  1
2016 Iosifescu DV, Neborsky RJ, Valuck RJ. The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy. Neuropsychiatric Disease and Treatment. 12: 2131-42. PMID 27601908 DOI: 10.2147/NDT.S113712  1
2016 Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV. Tissue Type Specific Bioenergetic Abnormalities in Adults with Major Depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27585738 DOI: 10.1038/Npp.2016.180  1
2016 Murrough JW, Abdallah CG, Anticevic A, Collins KA, Geha P, Averill LA, Schwartz J, DeWilde KE, Averill C, Jia-Wei Yang G, Wong E, Tang CY, Krystal JH, Iosifescu DV, Charney DS. Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Human Brain Mapping. PMID 27144347 DOI: 10.1002/Hbm.23235  1
2016 Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, et al. White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder. The Australian and New Zealand Journal of Psychiatry. PMID 27126391 DOI: 10.1177/0004867416644508  1
2016 Schwartz J, Murrough JW, Iosifescu DV. Ketamine for treatment-resistant depression: recent developments and clinical applications. Evidence-Based Mental Health. PMID 27053196 DOI: 10.1136/Eb-2016-102355  1
2016 Cassano P, Petrie SR, Hamblin MR, Henderson TA, Iosifescu DV. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis. Neurophotonics. 3: 031404. PMID 26989758 DOI: 10.1117/1.Nph.3.3.031404  1
2015 Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH. A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR). Journal of Psychiatric Research. 71: 126-33. PMID 26476489 DOI: 10.1016/j.jpsychires.2015.10.004  1
2015 Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV. Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry Journal. 2015: 352979. PMID 26356811 DOI: 10.1155/2015/352979  1
2015 Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, et al. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimulation. 8: 787-94. PMID 26143022 DOI: 10.1016/J.Brs.2015.05.005  1
2015 Iosifescu DV. Maintaining the initial clinical response after ketamine in bipolar and unipolar depression: an important next-step challenge. The Journal of Clinical Psychiatry. 76: 738-40. PMID 26132676 DOI: 10.4088/JCP.15com09904  0.01
2015 Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders. Journal of Affective Disorders. 184: 81-8. PMID 26074016 DOI: 10.1016/j.jad.2015.05.028  1
2015 Lener MS, Iosifescu DV. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. Annals of the New York Academy of Sciences. 1344: 50-65. PMID 25854817 DOI: 10.1111/nyas.12759  0.01
2015 Gonzalez Arnold J, Salcedo S, Ketter TA, Calabrese JR, Rabideau DJ, Nierenberg AA, Bazan M, Leon AC, Friedman ES, Iosifescu D, Sylvia LG, Ostacher M, Thase M, Reilly-Harrington NA, Bowden CL. An exploratory study of responses to low-dose lithium in African Americans and Hispanics. Journal of Affective Disorders. 178: 224-8. PMID 25827507 DOI: 10.1016/j.jad.2015.02.035  1
2015 Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Translational Psychiatry. 5: e509. PMID 25689570 DOI: 10.1038/Tp.2015.10  1
2015 Terroni L, Amaro E, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, Conforto AB, Sobreiro MF, Guajardo VD, De Lucia MC, Moreira AC, Scaff M, Leite CC, Fraguas R. The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region. Neuropsychiatric Disease and Treatment. 11: 233-42. PMID 25678790 DOI: 10.2147/NDT.S73722  1
2015 DeWilde KE, Levitch CF, Murrough JW, Mathew SJ, Iosifescu DV. The promise of ketamine for treatment-resistant depression: current evidence and future directions. Annals of the New York Academy of Sciences. 1345: 47-58. PMID 25649308 DOI: 10.1111/Nyas.12646  1
2015 Guajardo VD, Terroni L, Sobreiro Mde F, Zerbini MI, Tinone G, Scaff M, Iosifescu DV, de Lucia MC, Fráguas R. The influence of depressive symptoms on quality of life after stroke: a prospective study. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 24: 201-9. PMID 25440338 DOI: 10.1016/j.jstrokecerebrovasdis.2014.08.020  1
2015 Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, Foulkes A, Charney DS, Mathew SJ, Iosifescu DV. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1084-90. PMID 25374095 DOI: 10.1038/Npp.2014.298  1
2015 Wan LB, Levitch CF, Perez AM, Brallier JW, Iosifescu DV, Chang LC, Foulkes A, Mathew SJ, Charney DS, Murrough JW. Ketamine safety and tolerability in clinical trials for treatment-resistant depression. The Journal of Clinical Psychiatry. 76: 247-52. PMID 25271445 DOI: 10.4088/Jcp.13M08852  1
2015 Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, Gabrieli JD, Pizzagalli DA. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biological Psychiatry. 77: 285-94. PMID 25109665 DOI: 10.1016/J.Biopsych.2014.06.018  1
2015 Admon R, Nickerson LD, Dillon DG, Holmes AJ, Bogdan R, Kumar P, Dougherty DD, Iosifescu DV, Mischoulon D, Fava M, Pizzagalli DA. Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties. Psychological Medicine. 45: 121-31. PMID 25055809 DOI: 10.1017/S0033291714001123  1
2015 Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, ... Iosifescu DV, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial Psychological Medicine. DOI: 10.1017/S0033291715001506  1
2015 Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders Journal of Affective Disorders. 184: 81-88. DOI: 10.1016/j.jad.2015.05.028  1
2014 Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N. The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder. Journal of Affective Disorders. 169: 144-8. PMID 25194782 DOI: 10.1016/j.jad.2014.08.019  1
2014 Sobreiro MF, Miotto EC, Terroni L, Tinone G, Iosifescu DV, de Lucia MC, Scaff M, Leite Cda C, Amaro E, Fraguas R. Executive function and depressive symptoms of retardation in nonelderly stroke patients. Journal of Clinical and Experimental Neuropsychology. 36: 636-47. PMID 24974834 DOI: 10.1080/13803395.2014.925092  1
2014 Kaye JL, Dunlop BW, Iosifescu DV, Mathew SJ, Kelley ME, Harvey PD. Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: examining the convergence of performance-based measures and self-reports. Journal of Psychiatric Research. 57: 51-7. PMID 24974001 DOI: 10.1016/J.Jpsychires.2014.06.002  1
2014 Woods AG, Iosifescu DV, Darie CC. Biomarkers in major depressive disorder: the role of mass spectrometry. Advances in Experimental Medicine and Biology. 806: 545-60. PMID 24952202 DOI: 10.1007/978-3-319-06068-2_27  1
2014 Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Trials. 15: 240. PMID 24950747 DOI: 10.1186/1745-6215-15-240  1
2014 Rabideau DJ, Nierenberg AA, Sylvia LG, Friedman ES, Bowden CL, Thase ME, Ketter TA, Ostacher MJ, Reilly-Harrington N, Iosifescu DV, Calabrese JR, Leon AC, Schoenfeld DA. A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial. Clinical Trials (London, England). 11: 494-502. PMID 24872362 DOI: 10.1177/1740774514531096  1
2014 Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biological Psychiatry. 76: 970-6. PMID 24821196 DOI: 10.1016/J.Biopsych.2014.03.026  1
2014 Iacoviello BM, Wu G, Alvarez E, Huryk K, Collins KA, Murrough JW, Iosifescu DV, Charney DS. Cognitive-emotional training as an intervention for major depressive disorder. Depression and Anxiety. 31: 699-706. PMID 24753225 DOI: 10.1002/Da.22266  1
2014 Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. Jama Psychiatry. 71: 681-8. PMID 24740528 DOI: 10.1001/Jamapsychiatry.2014.62  1
2014 Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, Soleimani L, Charney DS, Foulkes AL, Mathew SJ. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depression and Anxiety. 31: 335-43. PMID 24668760 DOI: 10.1002/da.22253  1
2014 O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH. Rare copy number variation in treatment-resistant major depressive disorder. Biological Psychiatry. 76: 536-41. PMID 24529801 DOI: 10.1016/j.biopsych.2013.10.028  1
2014 Ostacher MJ, Iosifescu DV, Hay A, Blumenthal SR, Sklar P, Perlis RH. Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association. Bipolar Disorders. 16: 199-203. PMID 24372835 DOI: 10.1111/bdi.12143  1
2014 Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA. Medication adherence in a comparative effectiveness trial for bipolar disorder. Acta Psychiatrica Scandinavica. 129: 359-65. PMID 24117232 DOI: 10.1111/Acps.12202  1
2014 Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ, De La Garza R, Charney DS, Newton TF, Mathew SJ. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 331-6. PMID 24103211 DOI: 10.1017/S1461145713001119  1
2014 Friedman ES, Calabrese JR, Ketter TA, Leon AC, Thase ME, Bowden CL, Sylvia LG, Ostracher MJ, Severe J, Iosifescu DV, Nierenberg AA, Reilly-Harrington NA. Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials. Journal of Affective Disorders. 152: 97-104. PMID 23845385 DOI: 10.1016/j.jad.2013.05.052  1
2014 Beech RD, Leffert JJ, Lin A, Sylvia LG, Umlauf S, Mane S, Zhao H, Bowden C, Calabrese JR, Friedman ES, Ketter TA, Iosifescu DV, Reilly-Harrington NA, Ostacher M, Thase ME, et al. Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). The Pharmacogenomics Journal. 14: 182-91. PMID 23670706 DOI: 10.1038/tpj.2013.16  1
2014 Harper DG, Jensen JE, Ravichandran C, Sivrioglu Y, Silveri M, Iosifescu DV, Renshaw PF, Forester BP. Tissue-specific differences in brain phosphodiesters in late-life major depression American Journal of Geriatric Psychiatry. 22: 499-509. PMID 23567437 DOI: 10.1016/J.Jagp.2012.08.005  1
2014 Kemp DE, Sylvia LG, Calabrese JR, Nierenberg AA, Thase ME, Reilly-Harrington NA, Ostacher MJ, Leon AC, Ketter TA, Friedman ES, Bowden CL, Rabideau DJ, Pencina M, Iosifescu DV. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatrica Scandinavica. 129: 24-34. PMID 23465084 DOI: 10.1111/Acps.12101  1
2014 Hoogenboom WS, Perlis RH, Smoller JW, Zeng-Treitler Q, Gainer VS, Murphy SN, Churchill SE, Kohane IS, Shenton ME, Iosifescu DV. Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 122-34. PMID 22540406 DOI: 10.3109/15622975.2012.669499  1
2013 Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology. PMID 24022236 DOI: 10.1007/S00213-013-3255-X  1
2013 Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. The American Journal of Psychiatry. 170: 1134-42. PMID 23982301 DOI: 10.1176/Appi.Ajp.2013.13030392  1
2013 Sylvia LG, Iosifescu D, Friedman ES, Bernstein EE, Bowden CL, Ketter TA, Reilly-Harrington NA, Leon AC, Calabrese JR, Ostacher MJ, Rabideau DJ, Thase ME, Nierenberg AA. Use of treatment services in a comparative effectiveness study of bipolar disorder. Psychiatric Services (Washington, D.C.). 64: 1119-26. PMID 23945956 DOI: 10.1176/appi.ps.201200479  1
2013 Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 74: e636-41. PMID 23945458 DOI: 10.4088/Jcp.12M08093  1
2013 Reilly-Harrington NA, Sylvia LG, Leon AC, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Ostacher MJ, Iosifescu DV, Rabideau DJ, Thase ME, Nierenberg AA. The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. Journal of Psychiatric Research. 47: 1686-93. PMID 23911057 DOI: 10.1016/j.jpsychires.2013.07.009  1
2013 Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. The Journal of Clinical Psychiatry. 74: 51-6. PMID 23419226 DOI: 10.4088/Jcp.10M06813  1
2013 Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. QT interval and antidepressant use: a cross sectional study of electronic health records. Bmj (Clinical Research Ed.). 346: f288. PMID 23360890 DOI: 10.1136/bmj.f288  1
2013 Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, Ostacher MJ, Leon AC, Reilly-Harrington N, Iosifescu DV, Pencina M, Severe JB, Calabrese JR. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. The American Journal of Psychiatry. 170: 102-10. PMID 23288387 DOI: 10.1176/Appi.Ajp.2012.12060751  1
2013 Hoogenboom WS, Perlis RH, Smoller JW, Zeng-Treitler Q, Gainer VS, Murphy SN, Churchill SE, Kohane IS, Shenton ME, Iosifescu DV. Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study. Psychiatry Research. 211: 202-13. PMID 23149041 DOI: 10.1016/j.pscychresns.2012.07.007  1
2013 Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biological Psychiatry. 74: 250-6. PMID 22840761 DOI: 10.1016/J.Biopsych.2012.06.022  1
2013 Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, Iosifescu DV. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. The Australian and New Zealand Journal of Psychiatry. 47: 26-42. PMID 22711881 DOI: 10.1177/0004867412449303  1
2013 Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, ... ... Iosifescu DV, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry. 18: 497-511. PMID 22472876 DOI: 10.1038/Mp.2012.21  1
2012 Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. The American Journal of Psychiatry. 169: 1065-72. PMID 23032386 DOI: 10.1176/appi.ajp.2012.11091325  1
2012 Iosifescu DV. The relation between mood, cognition and psychosocial functioning in psychiatric disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: S499-504. PMID 22959115 DOI: 10.1016/j.euroneuro.2012.08.002  0.01
2012 Hoffman DA, Debattista C, Valuck RJ, Iosifescu DV. Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review. Neuropsychiatric Disease and Treatment. 8: 277-84. PMID 22802691 DOI: 10.2147/NDT.S31665  1
2012 Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. Cns Spectrums. 17: 76-86. PMID 22789065 DOI: 10.1017/S1092852912000430  1
2012 Castro VM, Gallagher PJ, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. Bmj Open. 2: e000544. PMID 22466034 DOI: 10.1136/bmjopen-2011-000544  1
2012 Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Iosifescu DV, Severe J, Keyes M, Nierenberg AA. Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder. Clinical Trials (London, England). 9: 94-101. PMID 22076437 DOI: 10.1177/1740774511427324  1
2012 Perlis RH, Iosifescu DV, Castro VM, Murphy SN, Gainer VS, Minnier J, Cai T, Goryachev S, Zeng Q, Gallagher PJ, Fava M, Weilburg JB, Churchill SE, Kohane IS, Smoller JW. Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychological Medicine. 42: 41-50. PMID 21682950 DOI: 10.1017/S0033291711000997  1
2012 Kanayama G, Hudson JI, Pope HG, Oe M, Schnyder U, Schumacher S, Mueller-Pfeiffer C, Wilhelm FH, Kalebasi N, Roos D, Hersberger M, Martin-Soelch C, Fava M, Mischoulon D, Iosifescu D, et al. Front & Back Matter Psychotherapy and Psychosomatics. 81. DOI: 10.1159/000337199  1
2011 Hoffman DA, Schiller M, Greenblatt JM, Iosifescu DV. Polypharmacy or medication washout: an old tool revisited. Neuropsychiatric Disease and Treatment. 7: 639-48. PMID 22090799 DOI: 10.2147/NDT.S24375  1
2011 Greenblatt JM, Sussman C, Jameson M, Yuan L, Hoffman DA, Iosifescu DV. Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders. Neuropsychiatric Disease and Treatment. 7: 529-41. PMID 21931495 DOI: 10.2147/NDT.S22271  1
2011 Santos DdM, Lage LV, Jabur EK, Kaziyama HHS, Iosifescu DV, de Lucia MCS, Fráguas R. The association of major depressive episode and personality traits in patients with fibromyalgia Clinics. 66: 973-978. PMID 21808861 DOI: 10.1590/S1807-59322011000600009  1
2011 Murrough JW, Iacoviello B, Neumeister A, Charney DS, Iosifescu DV. Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies Neurobiology of Learning and Memory. 96: 553-563. PMID 21704176 DOI: 10.1016/J.Nlm.2011.06.006  1
2011 Terroni L, Amaro E, Iosifescu DV, Tinone G, Sato JR, Leite CC, Sobreiro MF, Lucia MC, Scaff M, Fráguas R. Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 539-48. PMID 21486107 DOI: 10.3109/15622975.2011.562242  1
2011 Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. The Journal of Clinical Psychiatry. 72: 473-9. PMID 21208574 DOI: 10.4088/JCP.09m05131gry  1
2011 Soleimani L, Lapidus KA, Iosifescu DV. Diagnosis and treatment of major depressive disorder. Neurologic Clinics. 29: 177-93, ix. PMID 21172578 DOI: 10.1016/j.ncl.2010.10.010  1
2011 DeBattista C, Kinrys G, Hoffman D, Goldstein C, Zajecka J, Kocsis J, Teicher M, Potkin S, Preda A, Multani G, Brandt L, Schiller M, Iosifescu D, Fava M. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. Journal of Psychiatric Research. 45: 64-75. PMID 20598710 DOI: 10.1016/J.Jpsychires.2010.05.009  1
2010 Blood AJ, Iosifescu DV, Makris N, Perlis RH, Kennedy DN, Dougherty DD, Kim BW, Lee MJ, Wu S, Lee S, Calhoun J, Hodge SM, Fava M, Rosen BR, Smoller JW, et al. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. Plos One. 5: e13945. PMID 21124764 DOI: 10.1371/Journal.Pone.0013945  1
2010 Perlis RH, Smoller JW, Mysore J, Sun M, Gillis T, Purcell S, Rietschel M, Nöthen MM, Witt S, Maier W, Iosifescu DV, Sullivan P, Rush AJ, Fava M, Breiter H, et al. Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. The American Journal of Psychiatry. 167: 574-9. PMID 20360314 DOI: 10.1176/Appi.Ajp.2009.09070973  1
2010 Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, Ravichandran C, Iosifescu DV, Lukas SE, Renshaw PF, Cohen BM. Age-related changes in brain energetics and phospholipid metabolism. Nmr in Biomedicine. 23: 242-50. PMID 19908224 DOI: 10.1002/Nbm.1444  1
2010 Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). Cns Neuroscience & Therapeutics. 16: 322-5. PMID 19769599 DOI: 10.1111/J.1755-5949.2009.00102.X  1
2009 Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ, Fava M. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. Cns Spectrums. 14: 688-94. PMID 20394176 DOI: 10.1017/S1092852900023944  1
2009 Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Ketter TA, Calabrese JR, Thase ME, Bowden CL, Friedman ES, Ostacher MJ, Novak L, Iosifescu DV. Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. Clinical Trials (London, England). 6: 637-48. PMID 19933719 DOI: 10.1177/1740774509347399  1
2009 Iosifescu DV, Moore CM, Deckersbach T, Tilley CA, Ostacher MJ, Sachs GS, Nierenberg AA. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. Cns Neuroscience & Therapeutics. 15: 309-19. PMID 19889129 DOI: 10.1111/j.1755-5949.2009.00090.x  1
2009 Terroni LDMN, Fráguas R, De Lucia M, Tinone G, Mattos P, Iosifescu DV, Scaf M. Importance of retardation and fatigue/interest domains for the diagnosis of major depressive episode after stroke: A four months prospective study Revista Brasileira De Psiquiatria. 31: 202-207. PMID 19784486 DOI: 10.1590/S1516-44462009000300004  1
2009 Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research. 169: 124-31. PMID 19712979 DOI: 10.1016/J.Psychres.2009.06.004  1
2009 Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research. 169: 132-8. PMID 19709754 DOI: 10.1016/J.Psychres.2009.04.004  1
2009 Henriques SG, Fráguas R, Iosifescu DV, Menezes PR, de Lucia MCS, Gattaz WF, Martins MA. Recognition of depressive symptoms by physicians Clinics. 64: 629-635. PMID 19606237 DOI: 10.1590/S1807-59322009000700004  1
2009 Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M. Frontal EEG predictors of treatment outcome in major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 772-7. PMID 19574030 DOI: 10.1016/J.Euroneuro.2009.06.001  1
2009 Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. Contemporary Clinical Trials. 30: 205-11. PMID 19470312 DOI: 10.1016/j.cct.2009.01.007  1
2009 Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, Dougherty DD, Iosifescu DV, Rauch SL, Fava M. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. The American Journal of Psychiatry. 166: 702-10. PMID 19411368 DOI: 10.1176/appi.ajp.2008.08081201  1
2009 Fava M, Iosifescu DV, Pedrelli P, Baer L. Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire. Psychotherapy and Psychosomatics. 78: 91-7. PMID 19218827 DOI: 10.1159/000201934  1
2008 Makris N, Gasic GP, Kennedy DN, Hodge SM, Kaiser JR, Lee MJ, Kim BW, Blood AJ, Evins AE, Seidman LJ, Iosifescu DV, Lee S, Baxter C, Perlis RH, Smoller JW, et al. Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron. 60: 174-88. PMID 18940597 DOI: 10.1016/J.Neuron.2008.08.011  1
2008 Ostacher MJ, Nierenberg AA, Iosifescu DV, Eidelman P, Lund HG, Ametrano RM, Kaczynski R, Calabrese J, Miklowitz DJ, Sachs GS, Perlick DA. Correlates of subjective and objective burden among caregivers of patients with bipolar disorder. Acta Psychiatrica Scandinavica. 118: 49-56. PMID 18582347 DOI: 10.1111/j.1600-0447.2008.01201.x  1
2008 Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. Journal of Psychiatric Research. 43: 76-87. PMID 18433774 DOI: 10.1016/J.Jpsychires.2008.03.001  1
2008 Iosifescu DV, Greenwald S, Devlin P, Perlis RH, Denninger JW, Alpert JE, Fava M. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. Acta Psychiatrica Scandinavica. 117: 271-6. PMID 18307587 DOI: 10.1111/J.1600-0447.2008.01156.X  1
2008 Pizzagalli DA, Goetz E, Ostacher M, Iosifescu DV, Perlis RH. Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task. Biological Psychiatry. 64: 162-8. PMID 18242583 DOI: 10.1016/j.biopsych.2007.12.001  1
2007 Fraguas R, Iosifescu DV, Alpert J, Wisniewski SR, Barkin JL, Trivedi MH, Rush AJ, Fava M. Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. Psychosomatics. 48: 418-25. PMID 17878501 DOI: 10.1176/Appi.Psy.48.5.418  1
2007 Andrei AM, Fraguas R, Telles RM, Alves TC, Strunz CM, Nussbacher A, Rays J, Iosifescu DV, Wajngarten M. Major depressive disorder and inflammatory markers in elderly patients with heart failure. Psychosomatics. 48: 319-24. PMID 17600168 DOI: 10.1176/appi.psy.48.4.319  1
2007 Fraguas R, Marci C, Fava M, Iosifescu DV, Bankier B, Loh R, Dougherty DD. Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment Psychiatry Research. 151: 169-172. PMID 17360044 DOI: 10.1016/j.psychres.2006.08.008  1
2007 Iosifescu DV, Renshaw PF, Dougherty DD, Lyoo IK, Lee HK, Fraguas R, Cassano P, Nierenberg AA, Fava M. Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities. The Journal of Nervous and Mental Disease. 195: 175-8. PMID 17299307 DOI: 10.1097/01.nmd.0000253820.69362.87  1
2006 Fava M, Graves LM, Benazzi F, Scalia MJ, Iosifescu DV, Alpert JE, Papakostas GI. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of Clinical Psychiatry. 67: 1754-9. PMID 17196056 DOI: 10.4088/Jcp.V67N1113  1
2006 Papakostas GI, Worthington JJ, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, Homberger CH, Mischoulon D, Fava M. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depression and Anxiety. 23: 178-81. PMID 16528701 DOI: 10.1002/da.20181  1
2006 Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Perlis RH, Papakostas GI, Nierenberg AA, Fava M. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 188: 180-5. PMID 16449707 DOI: 10.1192/bjp.188.2.180  1
2006 Fraguas R, Henriques SG, Gonsalves Henriques S, De Lucia MS, Iosifescu DV, Schwartz FH, Menezes PR, Rossi Menezes P, Gattaz WF, Farid Gattaz W, Martins MA, Arruda Martins M. The detection of depression in medical setting: a study with PRIME-MD. Journal of Affective Disorders. 91: 11-7. PMID 16427132 DOI: 10.1016/J.Jad.2005.12.003  1
2006 Petersen T, Iosifescu DV, Papakostas GI, Shear DL, Fava M. Clinical characteristics of depressed patients with comorbid diabetes mellitus. International Clinical Psychopharmacology. 21: 43-47. PMID 16317316 DOI: 10.1097/01.Yic.0000182122.36425.B1  1
2006 Fraguas R, Henriques SG, De Lucia MS, Iosifescu DV, Schwartz FH, Menezes PR, Gattaz WF, Martins MA. Corrigendum to "The detection of depression in medical setting: A study with PRIME-MD" [Journal of Affective Disorders 91/1 (2006) 11-17] (DOI:10.1016/j.jad.2005.12.003) Journal of Affective Disorders. 96: 139. DOI: 10.1016/J.Jad.2006.05.010  1
2005 Papakostas GI, Petersen TJ, Green C, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M, Posternak MA. A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic Annals of Clinical Psychiatry. 17: 161-165. PMID 16433058 DOI: 10.1080/10401230591002129  1
2005 Iosifescu DV, Papakostas GI, Lyoo IK, Lee HK, Renshaw PF, Alpert JE, Nierenberg A, Fava M. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I). Psychiatry Research. 140: 291-9. PMID 16298109 DOI: 10.1016/j.pscychresns.2005.09.003  1
2005 Papakostas GI, Iosifescu DV, Renshaw PF, Lyoo IK, Lee HK, Alpert JE, Nierenberg AA, Fava M. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II). Psychiatry Research. 140: 301-7. PMID 16297603 DOI: 10.1016/J.Pscychresns.2005.09.001  1
2005 Iosifescu DV, Clementi-Craven N, Fraguas R, Papakostas GI, Petersen T, Alpert JE, Nierenberg AA, Fava M. Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder. Psychosomatic Medicine. 67: 703-6. PMID 16204427 DOI: 10.1097/01.Psy.0000170338.75346.D0  1
2005 Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 66: 1038-42. PMID 16086620 DOI: 10.4088/Jcp.V66N0812  1
2005 Petersen T, Papakostas GI, Posternak MA, Kant A, Guyker WM, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M. Empirical testing of two models for staging antidepressant treatment resistance. Journal of Clinical Psychopharmacology. 25: 336-341. PMID 16012276 DOI: 10.1097/01.Jcp.0000169036.40755.16  1
2005 Ongur D, Farabaugh A, Iosifescu DV, Perlis R, Fava M. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset. Psychotherapy and Psychosomatics. 74: 173-8. PMID 15832068 DOI: 10.1159/000084002  1
2005 Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, Rosenbaum JF, Fava M. Obesity among outpatients with major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 59-63. PMID 15361263 DOI: 10.1017/S1461145704004602  1
2004 Iosifescu DV, Nierenberg AA, Alpert JE, Papakostas GI, Perlis RH, Sonawalla S, Fava M. Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics. 45: 419-25. PMID 15345787 DOI: 10.1176/Appi.Psy.45.5.419  1
2004 Papakostas GI, Iosifescu DV, Petersen T, Hamill SK, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder. Journal of Clinical Psychopharmacology. 24: 467-9. PMID 15232350 DOI: 10.1097/01.Jcp.0000132343.58584.1D  1
2004 Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky KG, Alpert JE, Nierenberg AA, Fava M. Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. The Journal of Clinical Psychiatry. 65: 543-6. PMID 15119918 DOI: 10.4088/Jcp.V65N0414  1
2004 Papakostas GI, Ongür D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 135-42. PMID 15013029 DOI: 10.1016/S0924-977X(03)00099-3  1
2003 Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M. The impact of medical comorbidity on acute treatment in major depressive disorder. The American Journal of Psychiatry. 160: 2122-7. PMID 14638581 DOI: 10.1176/Appi.Ajp.160.12.2122  1
2003 Papakostas GI, Petersen T, Iosifescu DV, Roffi PA, Alpert JE, Rosenbaum JF, Fava M, Nierenberg AA. Axis III disorders in treatment-resistant major depressive disorder. Psychiatry Research. 118: 183-8. PMID 12798983 DOI: 10.1016/S0165-1781(03)00067-2  1
2003 Papakostas GI, Petersen T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, Fava M, Nierenberg AA. Serum cholesterol in treatment-resistant depression. Neuropsychobiology. 47: 146-51. PMID 12759558 DOI: 10.1159/000070584  1
2001 Iosifescu DV, Howarth S, Alpert JE, Nierenberg AA, Worthington JJ, Fava M. T3 blood levels and treatment outcome in depression. International Journal of Psychiatry in Medicine. 31: 367-73. PMID 11949735 DOI: 10.2190/6Fk8-Dbgl-Mwr1-Mv58  1
2000 Niznikiewicz M, Donnino R, McCarley RW, Nestor PG, Iosifescu DV, O'Donnell B, Levitt J, Shenton ME. Abnormal angular gyrus asymmetry in schizophrenia. The American Journal of Psychiatry. 157: 428-37. PMID 10698820 DOI: 10.1176/Appi.Ajp.157.3.428  1
1997 Wible CG, Shenton ME, Fischer IA, Allard JE, Kikinis R, Jolesz FA, Iosifescu DV, McCarley RW. Parcellation of the human prefrontal cortex using MRI. Psychiatry Research. 76: 29-40. PMID 9498307 DOI: 10.1016/S0925-4927(97)00060-7  1
1997 Iosifescu DV, Shenton ME, Warfield SK, Kikinis R, Dengler J, Jolesz FA, McCarley RW. An automated registration algorithm for measuring MRI subcortical brain structures. Neuroimage. 6: 13-25. PMID 9245652 DOI: 10.1006/Nimg.1997.0274  1
1996 Donnino R, Shenton ME, Iosifescu D, Hirokazu O, Wible CG, Kikinis R, Jolesz FA, McCarley RW. The parietal lobes in schizophrenia: A quantitative MR study Biological Psychiatry. 39: 639. DOI: 10.1016/0006-3223(96)84414-3  1
Show low-probability matches.